Annual report pursuant to Section 13 and 15(d)

Equity (Tables)

v3.22.1
Equity (Tables)
12 Months Ended
Dec. 31, 2021
Stockholders' Equity Note [Abstract]  
Schedule of stock option activity
(in thousands, except for per-share amount)   Number of
Options
    Weighted
Average
Exercise
Price
    Weighted
Average
Remaining
Contractual
Term
(in years)
    Aggregate
Intrinsic
Value at December 31, 2021
 
Outstanding, January 1, 2020     380       35.10       7.88       155  
Granted     458       9.99                  
Cancelled     (23 )     16.84                  
Outstanding, December 31, 2020     815       21.53       8.51       120  
Granted     881       6.43                  
Exercised     (1 )     6.69                  
Cancelled     (333 )     18.78                  
Outstanding, December 31, 2021     1,362       12.45       8.69       -  
                                 
Exercisable, December 31, 2021     354       27.04       6.92       -  

 

Schedule of warrant activities
(in thousands, except for per-share amounts)   Number of
Warrants
    Weighted
Average
Exercise
Price
    Weighted
Average
Remaining
Contractual
Term
(in years)
    Aggregate
Intrinsic
Value
 
Outstanding, January 1, 2020     2,871       20.71       2.95       301  
Granted     -       -                  
Exercised     (2 )     15.00                  
Cancelled     (756 )     20.99                  
Outstanding, December 31, 2020     2,113       20.55       2.76       362  
Granted     1       8.30                  
Exercised     -       -                  
Cancelled     (2 )     50.17                  
Outstanding, December 31, 2021     2,112       20.52       1.76       276  
                                 
Exercisable, December 31, 2021     2,108       20.12       1.76       276